H1'26 review: costs above expectations; est. & PT chg.

Aiforia H1'26 results: revenue confirmed at € 0.75m (-46% yoy), costs above est. PT cut to € 1.00 (old: € 1.10), HOLD reiterated. EIB tranche timing is key near-term variable.